SCHEMBL23846451

SCHEMBL23846451

COc1ccc(NC(=O)c2ccc3ncsc3c2)cc1S(=O)(=O)Nc1c(C)cccc1C

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.60
NPC1 O15118 11/20 0.60
KDM4E B2RXH2 6/20 0.60
MAPT P10636 6/20 0.60
KMT2A Q03164 10/20 0.57
MEN1 O00255 9/20 0.57
POLB P06746 4/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
GAA P10253 2/20 0.54
ALDH1A1 P00352 1/20 0.54
SMN1; SMN2 Q16637 4/20 0.50
MAPK1 P28482 1/20 0.50
LMNA P02545 3/20 0.48
HPGD P15428 1/20 0.48
GFER P55789 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
NAMPT P43490 1/20 0.48
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23846453 0.86 RAB9A (0.65) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL23846996 0.85 MAPT (0.54) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL23846444 0.84 NPC1 (0.58) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL23846629 0.83 KMT2A (0.47) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL23846440 0.83 NPC1 (0.56) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL23846415 0.82 MAPT (0.49) NPC1KDM4EMAPTKMT2AMEN1
SCHEMBL25758408 0.82 MAPT (0.57) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL23846398 0.82 NPC1 (0.52) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL23846441 0.81 PRNP (0.49) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL25758432 0.80 MAPT (0.49) NPC1KDM4EMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
WO-2021188880-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 RAB9A 650/4885NPC1 1821/4885KDM4E 4448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.